Jason Farley
Adult Nurse Practitioner, Johns Hopkins AIDS Service
Academic Degrees
Departmental Address
525 N. Wolfe Street, Room 450
Baltimore, MD 21205
Research and Professional Experience
My program of research centers around the prevention of drug resistant infections in vulnerable populations or high risk settings. Internationally, my current work focuses on understanding the infection control infrastructure in M(X)DR-TB care settings in South Africa leding to the development of intervention-based stuides. Locally, my ongoing work addresses the importance of drug resistant infections in high risk community populations. I am currently investigating CA-MRSA in newly admitted psychiatric patients at JHH as well as developing work on CA-MRSA in the HIV/AIDS population.
Keywords
Infection Control, infection prevention, drug-resistant infections, MDR-TB, XDR-TB, MRSA, international health, South Africa
Honors and Awards
Johns Hopkins Clinical Research Scholars Program
New Investigators Award, JHU SON
Fogarty Fellowship in Global Health, JHU SPH
Health Disparities Fellowship, P30 - NINR
Graduate Leadership Award
Margo Capra Award for Excellence in Hospital Epidemiology and Infection Control
Selected Publications
1. Farley, J.E. Ross T, Stamper PD, Speser S, Baucome S, Larson E, and Carroll KC. (2008). Prevalence, Risk Factors and Molecular Epidemilogy of MRSA among Newly Arrested Men in Maryland. American Journal of Infection Control. 36(9):644-650.
2. Farley, J.E. Stamper PD, Cai M, Ross T, Speser S, and Carroll KC. (2008). Comparison of the IDI-MRSA™ Assay to Culture Using BBLTM CHROMagar™ MRSA for Detection of MRSA from Nasal Surveillance Cultures in an At-Risk Population; 46(2):743-6. Journal of Clinical Microbiology.
3.Farley, J.E. (2008). Epidemiology, Clinical Manifestations and Treatment Options for Skin and Soft Tissue Infection Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA). The Journal of the American Academy of Nurse Practitioners. 20(2): 85-92.
4. Farley, J.E., Dial, D.J., Kearney, M. (2006). Management of Hematologic and Neuropsychiatric Side Effects in Persons Undergoing Treatment for Chronic HCV Infection. The Journal for Nurse Practitioners, 2(1); 38-45.
